Robin van Bruggen

Robin Van Bruggen has extensive work experience in the field of research and leadership roles. From 1998 to 2012, they worked as a Dr. at Sanquin. In 2015, they joined Sanquin again as a Group Leader, holding this position until 2018. During their time at Sanquin, they also became the Head of the Red Cell Research group in 2018. In the same year, they joined Sansepsis as the Chief Scientific Officer.

From 1994 to 1998, Robin Van Bruggen attended Vrije Universiteit Amsterdam (VU Amsterdam). No specific degree or field of study was mentioned.